COPENHAGEN (Reuters) – Denmark will keep its two-week suspension of AstraZeneca’s COVID-19 vaccine and decide on its future use next week following more investigations, the head of the country’s health agency said on Friday.
(Reporting by Jacob Gronholt-Pedersen; Editing by Alison Williams)